Characterisation of novel biomarkers for schizophrenia.
Mikey's research is in examining the role of modified human endothelial progenitor cells and mesenchynal stem cells in the treatment of cardiovasuclar disease.
Mesenchymal Stromal Cell Therapy for Acute Lung Injury
Stem cells, neuronal differentiation, CNS diseases and underlying mechanisms
Cardiovasular, Mesenchymal Stem Cells (MSCs), Angiogenic potential of microencapsulated MSCs
Cell therapy for diabetic foot ulcers
Mesenchymal stem cells, Haematopoietic stem cells, Stem Cell Biology
Professor of Zoology
Developmental Biology, Stem Cells in animals and marine organisms, the manipulation of key stem cells and their derivatives
Consultant Endocrinologist, Galway University Hospitals
Interests are delivering programmes of self-management education for people with diabetes and developing optimal models of community-based diabetes care.
Roisin investigates the potential of human MSCs as vectors for therapeutic gene delivery to breast tumor tissue
iPS stem cells, neuroscience
Scientific Director of REMEDI
The therapeutic application of adult stem cells, especially mesenchymal stem cells (MSCs) from bone marrow.
Cellular and Tissue Engineering Strategies for Bone Regeneration
Human MSCs for the treatment of lung ischemia/reperfusion
Professor of Anaesthesia, NUI Galway
Acute Lung Injury – pathogenesis and therapeutic strategies. Development of therapeutic strategies for acute lung injury and ARDS